Calculation
| Current ratio | = | Current assets1 | ÷ | Current liabilities1 | |
|---|---|---|---|---|---|
| Mar 31, 2022 | 7.05 | = | 976,473) | ÷ | 138,457) |
| Mar 31, 2021 | 6.11 | = | 787,965) | ÷ | 128,969) |
| Mar 31, 2020 | 4.82 | = | 635,863) | ÷ | 131,885) |
| Mar 31, 2019 | 6.39 | = | 677,197) | ÷ | 105,998) |
| Mar 31, 2018 | 5.84 | = | 494,271) | ÷ | 84,682) |
| Mar 31, 2017 | 4.70 | = | 326,958) | ÷ | 69,617) |
| Mar 31, 2016 | 6.20 | = | 288,392) | ÷ | 46,541) |
| Mar 31, 2015 | 5.60 | = | 220,139) | ÷ | 39,319) |
| Mar 31, 2014 | 3.88 | = | 117,966) | ÷ | 30,411) |
| Mar 31, 2013 | 4.31 | = | 116,605) | ÷ | 27,056) |
| Mar 31, 2012 | 4.93 | = | 110,539) | ÷ | 22,415) |
| Mar 31, 2011 | 3.79 | = | 84,737) | ÷ | 22,343) |
| Mar 31, 2010 | 4.58 | = | 82,668) | ÷ | 18,064) |
| Mar 31, 2009 | 5.03 | = | 88,489) | ÷ | 17,579) |
| Mar 31, 2008 | 3.67 | = | 71,503) | ÷ | 19,476) |
| Mar 31, 2007 | 7.47 | = | 96,382) | ÷ | 12,897) |
| Mar 31, 2006 | 5.31 | = | 46,443) | ÷ | 8,739) |
| Mar 31, 2005 | 11.31 | = | 55,224) | ÷ | 4,882) |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
1 US$ in thousands
The financial data reveals a sustained posture of high liquidity between 2005 and 2022, characterized by substantial growth in current assets that consistently outpaced the growth of current liabilities.
- Liquidity Ratio Trends
- The current ratio began at an exceptionally high level of 11.31 in 2005 before experiencing a period of contraction, reaching a low of 3.67 in 2008. Following this decline, the ratio remained relatively stable, fluctuating between 3.79 and 6.39 for the next twelve years. A renewed upward trajectory is observed from 2020 onward, with the ratio increasing from 4.82 to 7.05 by March 31, 2022.
- Asset and Liability Scaling
- Current assets expanded significantly from 55.2 million US dollars in 2005 to 976.5 million US dollars in 2022. While current liabilities also increased over the same period, rising from 4.9 million US dollars to 138.5 million US dollars, the absolute increase in assets was far more pronounced. A notable acceleration in asset accumulation occurred between 2014 and 2015, where current assets increased from 118 million US dollars to 220 million US dollars.
- Working Capital Position
- The consistently high current ratio indicates a conservative financial strategy with a significant buffer of short-term assets relative to short-term obligations. Throughout the entire period analyzed, the ratio never dropped below 3.67, suggesting a minimal risk of liquidity crises and an extensive capacity to meet immediate financial commitments.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Comparison to Competitors
| Abiomed Inc. | Abbott Laboratories | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|
| Mar 31, 2022 | 7.05 | 1.63 | 1.40 | 4.40 | 1.86 | 0.77 |
| Mar 31, 2021 | 6.11 | 1.85 | 1.47 | 5.08 | 2.65 | 0.79 |
| Mar 31, 2020 | 4.82 | 1.72 | 1.55 | 6.86 | 2.13 | 0.74 |
| Mar 31, 2019 | 6.39 | 1.44 | 1.65 | 4.53 | 2.59 | 0.69 |
| Mar 31, 2018 | 5.84 | 1.62 | 1.56 | 5.28 | 2.28 | 0.73 |
| Mar 31, 2017 | 4.70 | 2.26 | 1.55 | 3.99 | 1.75 | 0.73 |
| Mar 31, 2016 | 6.20 | 4.02 | 1.61 | 5.45 | 3.29 | 0.69 |
| Mar 31, 2015 | 5.60 | 1.54 | 1.62 | 4.46 | 3.36 | 0.74 |
| Mar 31, 2014 | 3.88 | 1.45 | 1.72 | 3.69 | 3.82 | 0.77 |
| Mar 31, 2013 | 4.31 | 2.02 | 1.82 | 5.07 | 4.57 | 0.73 |
| Mar 31, 2012 | 4.93 | 2.36 | 1.78 | 4.71 | 1.62 | 0.78 |
| Mar 31, 2011 | 3.79 | 1.54 | 1.71 | 4.57 | 1.93 | 0.85 |
| Mar 31, 2010 | 4.58 | 1.29 | 1.87 | 4.66 | 1.92 | 0.78 |
| Mar 31, 2009 | 5.03 | 1.79 | 1.91 | 4.18 | 2.37 | 0.82 |
| Mar 31, 2008 | 3.67 | 1.47 | 0.81 | 4.28 | 2.07 | 0.76 |
| Mar 31, 2007 | 7.47 | 1.54 | 0.91 | 4.63 | 3.09 | 0.84 |
| Mar 31, 2006 | 5.31 | 0.94 | 0.77 | 4.64 | 2.36 | 0.87 |
| Mar 31, 2005 | 11.31 | 1.54 | 1.75 | 3.60 | 2.20 | 0.64 |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
Comparison to Sector (Health Care Equipment & Services)
Abiomed Inc., current ratio, long-term trends, comparison to sector (health care equipment & services)
| Abiomed Inc. | Health Care Equipment & Services | |
|---|---|---|
| Mar 31, 2022 | 7.05 | 1.13 |
| Mar 31, 2021 | 6.11 | 1.22 |
| Mar 31, 2020 | 4.82 | 1.19 |
| Mar 31, 2019 | 6.39 | 1.17 |
| Mar 31, 2018 | 5.84 | 1.21 |
| Mar 31, 2017 | 4.70 | 1.24 |
| Mar 31, 2016 | 6.20 | 1.43 |
| Mar 31, 2015 | 5.60 | 1.36 |
| Mar 31, 2014 | 3.88 | 1.43 |
| Mar 31, 2013 | 4.31 | 1.54 |
| Mar 31, 2012 | 4.93 | 1.47 |
| Mar 31, 2011 | 3.79 | 1.36 |
| Mar 31, 2010 | 4.58 | 1.29 |
| Mar 31, 2009 | 5.03 | 1.46 |
| Mar 31, 2008 | 3.67 | 1.04 |
| Mar 31, 2007 | 7.47 | 1.14 |
| Mar 31, 2006 | 5.31 | 0.99 |
| Mar 31, 2005 | 11.31 | 1.31 |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
Comparison to Industry (Health Care)
| Abiomed Inc. | Health Care | |
|---|---|---|
| Mar 31, 2022 | 7.05 | 1.23 |
| Mar 31, 2021 | 6.11 | 1.31 |
| Mar 31, 2020 | 4.82 | 1.30 |
| Mar 31, 2019 | 6.39 | 1.48 |
| Mar 31, 2018 | 5.84 | 1.52 |
| Mar 31, 2017 | 4.70 | 1.55 |
| Mar 31, 2016 | 6.20 | 1.73 |
| Mar 31, 2015 | 5.60 | 1.70 |
| Mar 31, 2014 | 3.88 | 1.92 |
| Mar 31, 2013 | 4.31 | 1.96 |
| Mar 31, 2012 | 4.93 | 1.84 |
| Mar 31, 2011 | 3.79 | 1.94 |
| Mar 31, 2010 | 4.58 | 1.81 |
| Mar 31, 2009 | 5.03 | 1.78 |
| Mar 31, 2008 | 3.67 | 1.44 |
| Mar 31, 2007 | 7.47 | 1.53 |
| Mar 31, 2006 | 5.31 | 1.39 |
| Mar 31, 2005 | 11.31 | 1.63 |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).